
Primo Biotechnology
Operator of a molecular imaging platform intended to provide an accurate diagnosis of cancer. The company's platform specializes in non-invasive radiopharmaceutical imaging technology to detect early-...
Valuation
$0
Share Price
N/A
Total Raised
$9.9M
Last Round
N/A